{HEAD ~ Medrogestone} produced in {TAIL ~ accordance} with the process of this invention exhibits an HPLC strength in the order of 99.2% with total impurities at about 0.08% , thereby providing a very pure therapeutic agent 
produced in
{ HEAD ~ Medrogestone } produced in { TAIL ~ accordance } with the process of this invention exhibits an HPLC strength in the order of 99.2 % with total impurities at about 0.08 % , thereby providing a very pure therapeutic agent
HEAD HEAD HEAD HEAD HEAD REL REL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH